Literature DB >> 10511525

Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.

A E Chin1, K Hedberg, P R Cieslak, M Cassidy, K R Stefonek, D W Fleming.   

Abstract

With the emergence of drug-resistant Streptococcus pneumoniae, community-specific antimicrobial susceptibility patterns have become valuable determinants of empiric therapy for S. pneumoniae infections. Traditionally, these patterns are tracked by active surveillance for invasive disease, collection of isolates, and centralized susceptibility testing. We investigated whether a simpler and less expensive method aggregating existing hospital antibiograms--could provide community-specific antimicrobial susceptibility data. We compared 1996 active surveillance data with antibiogram data from hospital laboratories in Portland, Oregon. Of the 178 S. pneumoniae active surveillance isolates, 153 (86% [95% confidence interval (CI) = 80% to 91%]) were susceptible to penicillin. Of the 1,092 aggregated isolates used by hospitals to generate antibiograms, 921 (84% [95% CI = 82%-87%]) were susceptible to penicillin. With the exception of one hospital's erythromycin susceptibility results, hospital-specific S. pneumoniae susceptibilities to penicillin, cefotaxime, trimethoprim-sulfamethoxazole, and erythromycin from the two methods were statistically comparable. Although yielding fewer data than active surveillance, antibiograms provided accurate, community-specific drug-resistant S. pneumoniae data in Oregon.

Entities:  

Mesh:

Year:  1999        PMID: 10511525      PMCID: PMC2627721          DOI: 10.3201/eid0505.990510

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  9 in total

1.  Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.

Authors:  P A Frick; D J Black; J S Duchin; S Deliganis; W M McKee; T R Fritsche
Journal:  West J Med       Date:  1998-12

2.  Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

Authors:  G V Doern; M A Pfaller; K Kugler; J Freeman; R N Jones
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

3.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Authors:  H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

4.  The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System.

Authors:  J C Butler; J Hofmann; M S Cetron; J A Elliott; R R Facklam; R F Breiman
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

5.  A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.

Authors:  A J Leach; T M Shelby-James; M Mayo; M Gratten; A C Laming; B J Currie; J D Mathews
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

6.  Emergence of drug-resistant pneumococcal infections in the United States.

Authors:  R F Breiman; J C Butler; F C Tenover; J A Elliott; R R Facklam
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

7.  Laboratory survey of drug-resistant Streptococcus pneumoniae in New York City, 1993-1995.

Authors:  R Heffernan; K Henning; A Labowitz; A Hjelte; M Layton
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

Review 8.  Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.

Authors:  I R Friedland; G H McCracken
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

9.  The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio.

Authors:  M R Reichler; A A Allphin; R F Breiman; J R Schreiber; J E Arnold; L K McDougal; R R Facklam; B Boxerbaum; D May; R O Walton
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

  9 in total
  8 in total

1.  High prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma.

Authors:  R L Moolenaar; R Pasley-Shaw; J R Harkess; A Lee; J M Crutcher
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

2.  Active bacterial core surveillance of the emerging infections program network.

Authors:  A Schuchat; T Hilger; E Zell; M M Farley; A Reingold; L Harrison; L Lefkowitz; R Danila; K Stefonek; N Barrett; D Morse; R Pinner
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

3.  Sentinel surveillance: a reliable way to track antibiotic resistance in communities?

Authors:  Stephanie J Schrag; Elizabeth R Zell; Anne Schuchat; Cynthia G Whitney
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

4.  Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics.

Authors:  Cheryl R Stein; David J Weber; Meera Kelley
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

5.  Prevalence and antibiogram profiling of Escherichia coli pathotypes isolated from the Kat River and the Fort Beaufort abstraction water.

Authors:  Nolonwabo Nontongana; Timothy Sibanda; Elvis Ngwenya; Anthony I Okoh
Journal:  Int J Environ Res Public Health       Date:  2014-08-12       Impact factor: 3.390

6.  Hospital-reported pneumococcal susceptibility to penicillin.

Authors:  Joshua P Metlay; Charles C Branas; Neil O Fishman
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

7.  Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae.

Authors:  Chris A Van Beneden; Catherine Lexau; Wendy Baughman; Brenda Barnes; Nancy Bennett; P Maureen Cassidy; Margaret Pass; Lisa Gelling; Nancy L Barrett; Elizabeth R Zell; Cynthia G Whitney
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

8.  Evaluating antibiograms to monitor drug resistance.

Authors:  Mohamed El-Azizi; Adnan Mushtaq; Cheryl Drake; Jerry Lawhorn; Joan Barenfanger; Steven Verhulst; Nancy Khardori
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.